Evidence map›Paper›PMID 35836785›Full record

ArticleJournal of clinical and translational science2022

Using gamification to enhance clinical trial start-up activities.

Karen Lane, Ryan Majkowski, Joshua Gruber, Daniel Amirault, Shannon Hillery, Cortney Wieber, Dixie D Thompson, Jacqueline Huvane, Jordan Bridges, E Paul Ryu and 5 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Karen LaneJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Ryan MajkowskiJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Joshua GruberJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Daniel AmiraultJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-3938-7671
Shannon HilleryJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Cortney WieberTufts Medical Center, Boston, MA, USA.
Dixie D ThompsonUniversity of Utah, Salt Lake City, UT, USA.
Jacqueline HuvaneDuke Clinical Research Institute, Durham, NC, USA.
Jordan BridgesUniversity of Utah, Salt Lake City, UT, USA.
E Paul RyuJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Lindsay M EyzaguirreJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Marianne GildeaJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Richard E ThompsonJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Daniel E FordJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2549-2289
Daniel HanleyJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

COVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., BERNARD, GORDON RAPHAEL · 2016 to 2022
$177.0M
Utah Trial Innovation CenterU24TR001597 · NCATS · UNIVERSITY OF UTAH · PI DEAN, JONATHAN MICHAEL · 2016 to 2022
$39.6M
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN SupplementU24TR001609 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2016 to 2022
$36.3M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating CenterU01NS080824 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2013 to 2017
$23.2M
NCATS NIH HHS U24 TR001597NCATS NIH HHS U24 TR001608NCATS NIH HHS U24 TR001609NCATS NIH HHS UL1 TR002538NINDS NIH HHS U01 NS080824
6 · The paper itself

Abstract

Background: The Trial Innovation Network (TIN) is a collaborative initiative within the National Center for Advancing Translational Science (NCATS) Clinical and Translational Science Awards (CTSA) Program. To improve and innovate the conduct of clinical trials, it is exploring the uses of gamification to better engage the trial workforce and improve the efficiencies of trial activities. The gamification structures described in this article are part of a TIN website gamification toolkit, available online to the clinical trial scientific community. Methods: The game designers used existing electronic trial platforms to gamify the tasks required to meet trial start-up timelines to create friendly competitions. Key indicators and familiar metrics were mapped to scoreboards. Webinars were organized to share and applaud trial and game performance. Results: Game scores were significantly associated with an increase in achieving start-up milestones in activation, institutional review board (IRB) submission, and IRB approval times, indicating the probability of completing site activation faster by using games. Overall game enjoyment and feelings that the game did not apply too much pressure appeared to be an important moderator of performance in one trial but had little effect on performance in a second. Conclusion: This retrospective examination of available data from gaming experiences may be a first-of-kind use in clinical trials. There are signals that gaming may accelerate performance and increase enjoyment during the start-up phase of a trial. Isolating the effect of gamification on trial outcomes will depend on a larger sampling from future trials, using well-defined, hypothesis-driven statistical analysis plans.

Indexed as

clinical trialsGamificationmetricsTrial Innovation Networktrial start-up

Identifiers

PMID35836785
PMCPMC9274663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.